High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier

Bone Marrow Transplant. 2002 Feb;29(3):273-5. doi: 10.1038/sj.bmt.1703348.

Abstract

The epidemiology and clinical outcome of multiple myeloma in human immunodeficiency virus (HIV)-positive patients is poorly documented. There are uncertainties concerning the optimal management of this rare disorder. We report on the use of myeloablative chemotherapy with autologous stem cell transplantation in an HIV-positive patient with multiple myeloma.

Publication types

  • Case Reports

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Acquired Immunodeficiency Syndrome / therapy
  • Adult
  • Antigens, CD34 / blood*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Fatal Outcome
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Multiple Myeloma / therapy*
  • Multiple Myeloma / virology*
  • Transplantation, Autologous

Substances

  • Antigens, CD34